-
-
-
-
-
-
-
Entera Bio's EB613 data selected for presentation at ENDO 2026
-
-
-
-
-
-
-
Entera Bio outlines Q1 2026 milestones for osteoporosis drug
-
-
-
-
-
-
-
Entera Bio to present clinical data at September medical conferences
-
-
-
-
-
-
-
OPKO Health (OPK) and Entera Bio (ENTX) Enter into Collaboration Agreement
-
-
-
479,700 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


